Transaction #12977 · Form 4 · 0001193125-25-300677
Vera Therapeutics, Inc. · Stock award · Stock Option (right to buy)
Vera Therapeutics, Inc. · Transacted November 25, 2025 · Filed November 26, 2025
What does this filing report?
An SEC Form 4 filing for Vera Therapeutics, Inc. records a stock award involving Stock Option (right to buy) on November 25, 2025. The reported quantity was 25,000. The filing date is November 26, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Vera Therapeutics, Inc.
- Company CIK
- 0001831828
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 25,000
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 25,000
- Ownership description
- Not reported
- SEC acceptance time
- Nov 26, 2025, 4:37 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Meyers James R ↗
Director
CIK 0001387521
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Class A Common Stock
- Underlying quantity
- 25,000
- Conversion / exercise price
- 29.43
- Exercise date
- Not reported
- Expiration date
- November 24, 2035
Filing footnotes & remarks
- F1
- The shares subject to the stock option will vest monthly over a three-year period subject to the Reporting Person's continuous service on each vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.